Scleroderma Lung

Scleroderma-related interstitial lung disease (SSc-ILD) is a pulmonary fibrosing disorder characterized by systemic inflammation and…

Pulmonary Progression Can be Rapid in SSc

Even in early systemic sclerosis, almost half had PAH

SPAR Predicts ILD Progression in Systemic Sclerosis

The development and progression of interstitial lung disease in systemic sclerosis can be an…

SPAR: SpO2 <94% after 6-minute walk test + ARthritis has almost 92% predictive value for interstitial lung disease worsening in SSc.

ILD worsening at 1 year is defined as >15% drop in FVC, or, >10% drop in FVC + >15% drop in DLCO.

Response to: ‘Can we further SPARkle the SPAR model?’ by Kavadichanda et al

Thank you very much for your interest in our article ‘Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the…